Stay updated on ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Sign up to get notified when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.

Latest updates to the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page now shows Revision: v3.4.3, and related-topic links such as Cystic Fibrosis related topics and MedlinePlus Genetics were removed.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded related topics links for Cystic fibrosis and MedlinePlus Genetics. These are supplementary navigation aids and do not alter core study content or decisions about participation.SummaryDifference0.2%

- Check40 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding lapse notice and related topics such as Cystic fibrosis and Revision: v3.4.1.SummaryDifference0.6%

- Check47 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated operating status information; the page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check54 days agoChange DetectedAdditions include Show glossary, Cystic fibrosis, related topics (MedlinePlus Genetics), and metadata updates (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); deletions remove Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ALX-009 Dose Escalation in Bronchiectasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALX-009 Dose Escalation in Bronchiectasis Clinical Trial page.